LPL / Lipoprotein Lipase

Lipoprotein Lipase antibody LS-C188628 is an unconjugated mouse monoclonal antibody to bovine Lipoprotein Lipase (LPL). Validated for ELISA, IP and WB.

Antibodies Primary

Article No

LS-C188628-0.5

Species Reactivity

cow/bovine

Size

0.5 mg

Clone

5D2

Source / Host

mouse

Shipping Information

RT

Application

ELISA, IP, WB

Article No

LS-C188628-0.5

Species Reactivity

cow/bovine

Size

0.5 mg

Clone

5D2

Source / Host

mouse

Shipping Information

RT

Application

ELISA, IP, WB

Specifications

NCBI Number 4023
Application ELISA, IP, WB
Article No LS-C188628-0.5
Country Availability SE, FI, DK, NO, FO, GL
Clone 5D2
Clone Type monoclonal
Concentration 1 mg/ml
Conjugation Unconjugated
Description Lipoprotein Lipase antibody LS-C188628 is an unconjugated mouse monoclonal antibody to bovine Lipoprotein Lipase (LPL). Validated for ELISA, IP and WB.
Recommended Dilution ELISA (1:500 - 1:5000)
Supplier LifeSpan Biosciences
Entrez Gene ID 4023
Gene Symbol LPL
Immunogen Purified bovine milk lipoprotein lipase.
Isotype IgG1
Notes Lipoprotein Lipase antibody LS-C188628 is an unconjugated mouse monoclonal antibody to bovine Lipoprotein Lipase (LPL). Validated for ELISA, IP and WB.
Alias Names LPL, LIPD, Lipoprotein lipase, HDLCQ11
Product Type Antibodies Primary
Protocol The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.
Purification Protein G Purified
Shipping Information RT
Size 0.5 mg
Source / Host mouse
Species Reactivity cow/bovine
Storage -20°C
Substrate / Buffer PBS
Technical Specifications Recognizes an epitope within amino acids 380-410 of lipoprotein lipase (LPL), a member of the AB hydrolase superfamily, which plays a pivotal role in lipoprotein metabolism and transport, acting as the key enzyme in the hydrolysis of triglycerides and very low density lipoproteins (VLDLs), and the release of free fatty acids into peripheral tissues. A deficiency of LPL can result in hypertriglyceridemia, and many studies have focused on the critical role which LPL plays in the pathogenesis of atherosclerosis, and in particular the relationship between LPL and apolipoprotein E (ApoE), both of which are secreted in significant amounts by macrophages in developing arterial wall lesions. Clone 5D2 is a unique antibody which differentiates between monomeric inactive and dimeric active LPL, and binds to LPL sequences involved in LPL, LPL receptor, and heparin interactions. Clone 5D2 has been shown to inhibit the activity of human LPL(2,3), and is widely used in human studies.
Product Page Updated 2024-04-12T06:35:05.844Z

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more